1. Home
  2. ZYXI

as of 12-12-2025 4:00pm EST

$0.74
$0.12
-14.20%
Stocks Health Care Biotechnology: Electromedical & Electrotherapeutic Apparatus Nasdaq

Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.

Chart Type:
Time Range:
Founded: 1996 Country:
United States
United States
Employees: N/A City: ENGLEWOOD
Market Cap: 35.8M IPO Year: N/A
Target Price: $3.00 AVG Volume (30 days): 14.6M
Analyst Decision: Hold Number of Analysts: 3
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -2.39 EPS Growth: N/A
52 Week Low/High: $0.38 - $8.72 Next Earning Date: 11-17-2025
Revenue: $108,202,000 Revenue Growth: -44.13%
Revenue Growth (this year): -49.43% Revenue Growth (next year): 9.30%

AI-Powered ZYXI Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 3 days ago

AI Recommendation

hold
Model Accuracy: 82.07%
82.07%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: